Program Book - Confex

ACR/ARHP Poster Session B
Rheumatic Diseases, Pune, India, 3 Sinhgad College of
Engineering, Pune, India, 4 Gokhale Institute of Politics and
Economics, Pune, India, 5 Symbiosis International University,
Pune - 41104 2 , India
1256. Design of a High Potency CTLA4-Ig with Extended Half-Life
for Improved Dosing Convenience. Matthew J. Bernett,
Seung Y. Chu, Holly M. Horton, Erik Pong, Irene Leung,
Gregory L. Moore, Umesh S. Muchhal, Greg A. Lazar,
David E. Szymkowski and John R. Desjarlais, Xencor, Inc.,
Monrovia, CA
1257. Campylobacter Fetus Infection In Three Patients
Treated with Rituximab for Rheumatoid Arthritis.
Alain Meyer 1 , Arnaud Theulin 2 , Emmanuel Chatelus 3 ,
Christelle Sordet 2 , Rose-Marie Javier 2 , Helene Chifflot 4 ,
Jacques-Eric Gottenberg 5 and Jean Sibilia 6 , 1 Hautepierre
Strasbourg university, Strasbourg, France, 2 Hautepierre
Strasbourg Hospital University, Strasbourg, France, 3 Hopital
Hautepierre, Strasbourg, France, 4 Hautepierre Strasbourg
Hospital University, 6 7000, France, 5 Strasbourg University
Hospital, Strasbourg, France, 6 Service de rhumatologie,
Hôpitaux Universitaires de Strasbourg, Strasbourg, France,
Strasbourg, France
1258. Short- and Long-Term Effect of Unguided, Intra-Articular
Injections with Betamethasone In Early Rheumatoid
Arthritis. Impact of Joint Area, Repeated Injections, MRI
Findings, Anti-CCP, IgM-RF and CRP. Merete L. Hetland 1 ,
Mikkel Østergaard 2 , Bo J. Ejbjerg 3 , Søren Jacobsen 4 , Kristian
Stengaard-Pedersen 5 , Peter Junker 6 , Tine Lottenburger 6 , Ib
Hansen 7 , Lis Smedegaard Andersen 8 , Ulrik Tarp 9 , Anders
Svendsen 10 , Jens Kristian Pedersen 6 , Henrik Skjødt 11 ,
Torkell Ellingsen 12 , Hanne M. Lindegaard 6 and Kim
Hørslev-Petersen 13 , 1 Copenhagen University Hospital at
Glostrup, on behalf of DANBIO, Copenhagen, Denmark,
2
Copenhagen University Hospital in Glostrup, Glostrup,
Denmark, 3 Hospital at Slagelse, Slagelse, Denmark,
4
Rigshospitalet - 4242, Copenhagen, Denmark, 5 Department
of Rheumatology, Aarhus University Hospital, Aarhus,
Denmark, 6 Odense University Hospital, Odense C, Denmark,
7
Viborg Hospital, Viborg, Denmark, 8 Denmark, 9 Aarhus
University Hospital, Aarhus, Denmark, 10 Odense, Denmark,
11
Copenhagen University Hospital at Glostrup, Copenhagen,
Denmark, 12 University Hospital, Silkeborg, Denmark,
13
University of Southern Denmark, Graasten, Denmark
1259. Pharmacokinetic-Pharmacodynamic Modeling of
Ozoralizumab (ATN-103), a Novel Humanized Nanobody
Tumor Necrosis Factor Inhibitor for Rheumatoid
Arthritis. Chandrasekhar Udata 1 , Arnab Mukherjee 2 , Matt
Hutmacher 3 , Mark Peterson 1 , Kai-Hsin Liao 1 , Tina Checchio 2 ,
Kathy Shields 4 , Xu Meng 1 and Gail Comer 4 , 1 Pfizer, San
Diego, CA, 2 Pfizer, Groton, CT, 3 A2PG, Ann Arbor, MI, 4 Pfizer,
Collegeville, PA
1260. Correlation of CDAI and SDAI with DAS in a Large Real-
Life Cohort of Rheumatoid Arthritis Patients Treated with
Infliximab. Denis Choquette 1 , William G. Bensen 2 , Milton
F. Baker 3 , Sophie Elise Michaud 4 and Hayssam Khalil 5 ,
1
University of Montreal, Notre-dame Hospital, Montreal,
QC, 2 McMaster University, Hamilton, ON, Hamilton, ON,
3
VIHA, Victoria, BC, 4 Merck Canada Inc, Montreal, QC,
5
Merck Canada Inc, Kirkland, QC
1261. Development of a Whole Blood Assay to Determine
Rituximab Mediated Complement Dependent Cytotoxicity
of B Lymphocytes. Jonathan D. Jones 1 , B. JoNell Hamilton 2 ,
Whitney Hilton 3 and William F. C. Rigby 4 , 1 Dartmouth-
Hitchcock Medical Center, Lebanon, NH, 2 Dartmouth
College, Lebanon, NH, 3 Dartmouth Hitchcock Med Ctr,
Lebanon, NH, 4 Dartmouth-Hitchcock Med Ctr, Lebanon, NH
1262. A Profile of Rheumatoid Arthritis Patients Treated with
Tocilizumab in a United States Registry Population.
Dimitrios A. Pappas 1 , Alan Rathbun 2 , George Reed 3 , Joel M.
Kremer 4 , Isidro Villanueva 5 , Jenny Devenport 6 , Sarika Ogale 6 ,
Ani John 6 and Jeffrey D. Greenberg 7 , 1 Columbia University,
College of Physicians & Surge, New York, NY, 2 UMASS
Medical School, Worcester, MA, 3 UMass Medical School,
Worcester, MA, 4 Albany Medical College and The Center
for Rheumatology, Albany, NY, 5 Viregen Macarena Hospital,
Sevilla, Spain, 6 Genentech, South San Francisco, CA, 7 New
York University School of Medicine, New York, NY
1263. SNP Algorithms for Prediction of Efficacy and Adverse
Events of Abatacept. Tsukasa Matsubara 1 , Satoru Koyano 2 ,
Keiko Funahashi 2 , Takafumi Hagiwara 1 , Takako Miura 1 ,
Kosuke Okuda 1 , Takeshi Nakamura 1 , Mitsuyoshi Iwahashi 3 ,
Tomomi Tsuru 4 , Shoichi Uchimura 5 and Shigeru Honjo 6 ,
1
Matsubara Mayflower Hospital, Kato, Japan, 2 Research
Institute of Joint Diseases, Kobe, Japan, 3 Higashi-Hiroshima
Memorial Hospital, Higashi-hiroshima, Japan, 4 PS Clinic,
Fukuoka, Japan, 5 Kanzaki Municipal General Hospital,
Kanzaki, Japan, 6 Honjo Rheumatism Clinic, Takaoka, Japan
1264. Low Persistence of Methotrexate Monotherapy in the
Veterans Affairs Rheumatoid Arthritis (VARA) Registry.
Grant W. Cannon 1 , Brian C. Sauer 1 , Katherine L. Martin 1 ,
Candace L. Hayden 1 , Andreas M. Reimold 2 , Liron Caplan 3 ,
J. Steuart Richards 4 , Gail S. Kerr 4 , Dannette S. Johnson 5
and Ted R. Mikuls 6 , 1 Salt Lake City VA and University of
Utah, Salt Lake City, UT, 2 Dallas VA and University of Texas
Southwestern, Dallas, TX, 3 Denver VA and University of
Colorado, Aurora, CO, 4 Washington DC VA and Georgetown
University, Washington, DC, 5 Jackson VA and University of
Mississippi Medical Center, Jackson, MS, 6 Omaha VA and
University of Nebraska, Omaha, NE
1265. Effects of TNF-Alpha Inhibitors on Lipid Profile and on Sub-
Clinical Atherosclerosis in Rheumatoid Arthritis. Systematic
Review and Meta-Analysis. Sylvain Mathieu 1 , Sarah
Payet 1 , Bruno Pereira 2 , Eric Bruckert 3 and Martin Soubrier 2 ,
1
CHU Gabriel Montpied, Clermont-Ferrand, France, 2 CHU
CLERMONT-FERRAND, Clermont-Ferrand, France, 3 CHU Pitié-
Salpêtrière, AP–HP, Paris
2011 Program Book 225